Advertisement

The Scientist

» Myriad Genetics Inc.

Most Recent

image: Another Legal Setback for Myriad

Another Legal Setback for Myriad

By | March 11, 2014

A judge declines Myriad Genetics’s request to block its competitors from selling BRCA tests.  

0 Comments

image: The Scientist on The Pulse #2

The Scientist on The Pulse #2

By | January 8, 2014

Kerry Grens looks back at the biggest science stories in 2013

0 Comments

image: Governing Science

Governing Science

By | December 31, 2013

How the US government impacted life science research in 2013

1 Comment

image: Another Lawsuit over Genetic Tests

Another Lawsuit over Genetic Tests

By | July 11, 2013

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.

0 Comments

image: Court Rules Gene Patents Valid

Court Rules Gene Patents Valid

By | August 17, 2012

Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.

8 Comments

image: Gene Patents Back in Court

Gene Patents Back in Court

By | June 19, 2012

A public interest legal group has renewed the fight against DNA patenting.

0 Comments

image: Courts Re-Examining Gene Patents

Courts Re-Examining Gene Patents

By | March 28, 2012

The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.

2 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies